LRRK2 and Parkinson disease: Urate, an activator of NRF2, was elevated in LRRK2 mutation carriers resistant to PD [187]; the authors of that study suggested that peripheral urate levels could prevent the emergence of PD by activating NRF2-dependent pathways.